Powered by 
Google Übersetzer
Google Übersetzer
18 February 2025
ECO Animal Health Group plc
("ECO" or the "Company")
BLOCK LISTING RETURN
|
Name of applicant: |
ECO Animal Health Group plc |
|||
|
Name of scheme: |
Executive Share Option Scheme and Unapproved Share Option Scheme |
|||
|
Number and class of securities originally listed and the date of admission: |
1,500,000 ordinary shares of 5 pence each on 20 July 2017 |
|||
|
Period of return: |
From: |
9 August 2024 |
To: |
9 February 2025 |
|
Balance of unallotted securities under scheme(s) from previous return: |
375,505 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period: |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
375,505
|
|||
|
|
|
|
|
|
-Ends-
For further information please contact:
|
|
About ECO Animal Health
ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.
Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.
Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.
Click here for more information: https://ecoanimalhealth.com
